Vitiligo vulgaris is an autoimmune disorder that causes loss of pigmentation over the skin, hair and mucous membranes (e.g. lips, nose, genitals). While genes have been identified that are thought to be required for development of vitiligo, only 5-10% of relatives develop disease. The triggers for disease onset have not yet been identified. The intent of this study is to research trends in laboratory data, social and medical history that may be contributory to vitiligo onset, location of disease, course of illness and response to therapy.

Patients who participate in this study will be asked to complete a survey and have blood/ laboratory testing performed that relates or may relate to the diagnosis of vitiligo.

Inclusion Criteria:

• Diagnosis of Vitiligo Vulgaris
• Ability to sign consent

Exclusion Criteria:

• Pregnant
• Inability to sign consent
• Inability to complete questionnaire

All patients willing to sign consent, complete questionnaire and/ or laboratory studies.